Urinary bladder transplantation in humans - current status and future perspectives.
Michał C CzarnogórskiKrzysztof KoperPiotr PetraszMalte W VetterleinMarta PokrywczyńskaKajetan JuszczakTomasz DrewaJan AdamowiczPublished in: Nature reviews. Urology (2024)
Urinary bladder vascularized allograft transplantation in humans is currently extensively being investigated worldwide, owing to the theoretical potential of this approach as a therapeutic option for individuals with end-stage, non-oncological bladder conditions or congenital bladder pathologies. To date, a successful attempt at urinary bladder autotransplantation was carried out in a heart-beating brain-dead research human donor. The robot-assisted surgical technique was shown to be optimal for performing this procedure, achieving a good performance in terms of both bladder allograft collection as well as vascular, ureterovesical and vesicourethral anastomoses. The urinary bladder vascularized allograft would be an alternative to traditional urinary diversion methods that rely on the use of intestinal segments, potentially avoiding adverse effects associated with these approaches. However, different from ileal urinary diversion, bladder transplantation would require lifelong immune suppression. Clinical trials are in progress to assess the vascularized bladder allograft transplantation technique, as well as the safety of this procedure in oncological and non-oncological indications.
Keyphrases
- robot assisted
- minimally invasive
- spinal cord injury
- clinical trial
- urinary tract
- cell therapy
- kidney transplantation
- rectal cancer
- endothelial cells
- heart failure
- radical prostatectomy
- stem cells
- multidrug resistant
- randomized controlled trial
- white matter
- multiple sclerosis
- mass spectrometry
- brain injury
- high resolution